These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 22815234)

  • 1. Cannabidiol in inflammatory bowel diseases: a brief overview.
    Esposito G; Filippis DD; Cirillo C; Iuvone T; Capoccia E; Scuderi C; Steardo A; Cuomo R; Steardo L
    Phytother Res; 2013 May; 27(5):633-6. PubMed ID: 22815234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon.
    Couch DG; Tasker C; Theophilidou E; Lund JN; O'Sullivan SE
    Clin Sci (Lond); 2017 Nov; 131(21):2611-2626. PubMed ID: 28954820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in inflammatory bowel diseases in children.
    Michail S; Ramsy M; Soliman E
    Minerva Pediatr; 2012 Jun; 64(3):257-70. PubMed ID: 22555319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice.
    Sann H; Erichsen Jv; Hessmann M; Pahl A; Hoffmeyer A
    Life Sci; 2013 Apr; 92(12):708-18. PubMed ID: 23399699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis use amongst patients with inflammatory bowel disease.
    Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case for assessing cannabidiol in epilepsy.
    Cilio MR; Thiele EA; Devinsky O
    Epilepsia; 2014 Jun; 55(6):787-90. PubMed ID: 24854434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.
    Couch DG; Cook H; Ortori C; Barrett D; Lund JN; O'Sullivan SE
    Inflamm Bowel Dis; 2019 May; 25(6):1006-1018. PubMed ID: 31054246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
    Scuderi C; Filippis DD; Iuvone T; Blasio A; Steardo A; Esposito G
    Phytother Res; 2009 May; 23(5):597-602. PubMed ID: 18844286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing therapy for inflammatory bowel disease.
    Robinson M
    Am J Gastroenterol; 1997 Dec; 92(12 Suppl):12S-17S. PubMed ID: 9395347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.
    Naftali T; Mechulam R; Marii A; Gabay G; Stein A; Bronshtain M; Laish I; Benjaminov F; Konikoff FM
    Dig Dis Sci; 2017 Jun; 62(6):1615-1620. PubMed ID: 28349233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor.
    Ribeiro A; Ferraz-de-Paula V; Pinheiro ML; Vitoretti LB; Mariano-Souza DP; Quinteiro-Filho WM; Akamine AT; Almeida VI; Quevedo J; Dal-Pizzol F; Hallak JE; Zuardi AW; Crippa JA; Palermo-Neto J
    Eur J Pharmacol; 2012 Mar; 678(1-3):78-85. PubMed ID: 22265864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current medical therapy for chronic inflammatory bowel diseases.
    Tamboli CP
    Surg Clin North Am; 2007 Jun; 87(3):697-725. PubMed ID: 17560421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General principles of medical therapy of inflammatory bowel disease.
    Friedman S
    Gastroenterol Clin North Am; 2004 Jun; 33(2):191-208, viii. PubMed ID: 15177534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjects.
    Eichler M; Spinedi L; Unfer-Grauwiler S; Bodmer M; Surber C; Luedi M; Drewe J
    Planta Med; 2012 May; 78(7):686-91. PubMed ID: 22411724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of natural products actions on cytokines in inflammatory bowel disease.
    Hur SJ; Kang SH; Jung HS; Kim SC; Jeon HS; Kim IH; Lee JD
    Nutr Res; 2012 Nov; 32(11):801-16. PubMed ID: 23176791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of therapy for inflammatory bowel disease.
    Burri E; Beglinger C; Lehmann FS
    Digestion; 2012; 86 Suppl 1():1-5. PubMed ID: 23051719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review.
    Algieri F; Rodriguez-Nogales A; Rodriguez-Cabezas ME; Risco S; Ocete MA; Galvez J
    Mediators Inflamm; 2015; 2015():179616. PubMed ID: 26576073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer.
    Kis B; Ifrim FC; Buda V; Avram S; Pavel IZ; Antal D; Paunescu V; Dehelean CA; Ardelean F; Diaconeasa Z; Soica C; Danciu C
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775230
    [No Abstract]   [Full Text] [Related]  

  • 20. The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series.
    Sandhu A; Alameel T; Dale CH; Levstik M; Chande N
    Aliment Pharmacol Ther; 2012 Jul; 36(2):159-65. PubMed ID: 22616981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.